Impact of placental malaria and hypergammaglobulinemia on transplacental transfer of respiratory syncytial virus antibody in Papua New Guinea

Journal of Infectious Diseases

Volumn 213, Issue 3, 2016, Pages 423-431

  Atwell, Jessica E ^a   Thumar, Bhagvanji ^a   Robinson, Leanne J ^b,c   Tobby, Roselyn ^b   Yambo, Phantica ^b   Ome Kaius, Maria ^b   Siba, Peter M ^b,d   Unger, Holger W ^c   Rogerson, Stephen J ^c   King, Christopher L ^e   Karron, Ruth A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d JAMES COOK UNIVERSITY   (Australia)

^e CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

hypergammaglobulinemia; maternal immunization; placental malaria; RSV; transplacental transfer of antibody

Indexed keywords

IMMUNOGLOBULIN G; NEUTRALIZING ANTIBODY; RESPIRATORY SYNCYTIAL VIRUS ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; MAJOR CLINICAL STUDY; PAPUA NEW GUINEA; PASSIVE IMMUNIZATION; PLACENTA MALARIA; PLACENTAL TRANSFER; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; COHORT ANALYSIS; COMPLICATION; FETUS BLOOD; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOLOGY; MALARIA; METABOLISM; MIDDLE AGED; PARASITOLOGY; PLACENTA DISORDER; PREGNANCY; PREGNANCY COMPLICATION; RISK FACTOR; TRANSMISSION; VERTICAL TRANSMISSION; VIRAL PLAQUE ASSAY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; COHORT STUDIES; FEMALE; FETAL BLOOD; HUMANS; HYPERGAMMAGLOBULINEMIA; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALARIA; MIDDLE AGED; PAPUA NEW GUINEA; PLACENTA DISEASES; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; RESPIRATORY SYNCYTIAL VIRUSES; RISK FACTORS; VIRAL PLAQUE ASSAY; YOUNG ADULT;

EID: 84960342409     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv401     Document Type: Article

References (39)

1. Liu L, Oza S, Hogan D,. et al. Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2014; 6736: 2013-4.
2. Hall CB, Weinberg GA, Poehling KA, Erdman D, Grijalva CG, Zhu Y. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009; 360: 588-98.
3. Nair H, Nokes JD, Gessner BD,. et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-Analysis. Lancet 2010; 375: 1545-55.
4. Hemming VG, Prince GA, Groothuis JR, Siber GR. Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections. Clin Microbiol Rev 1995; 8: 22-33.
5. Siber GR, Leombruno D, Leszczynski J,. et al. Comparison of antibody concentrations and protective activity of respiratory syncytial virus immune globulin and conventional immune globulin. J Infect Dis 1994; 169: 1368-73.
6. Groothuis JR, Simoes EA, Levin MJ,. et al. Prophylactic Administration of RSV immune globulin to high-risk infants and young children. N Engl J Med 1993; 329: 1524-30.
7. Glezen WP, Paredes A, Allison JE, Taber LH, Frank AL. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981; 98: 708-15.
8. IMpact-RSV Study Group, IMpact Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998; 102: 531-7.
9. Eick A, Karron R, Shaw J,. et al. The role of neutralizing antibodies in protection of American Indian infants against respiratory syncytial virus disease. Pediatr Infect Dis J 2008; 27: 207-12.
10. Anderson LJ, Dormitzer PR, Nokes DJ, Rappuoli R, Roca A, Graham BS. Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine 2013; 31: B209-15.
11. Graham BS, Anderson LJ. Challenges and opportunities for respiratory syncytial virus vaccines. Cur Top Microbiol Immunol 2013; 372: 391-404.
12. Karron RA. Respiratory syncytial virus and parainfluenza virus. In: Plotkin S, Orenstein W, Offit P, eds. Vaccines. 6th ed. Philadelphia: Elsevier Saunders Inc., 2012: 1146-53.
13. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M. IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012; doi: 10.1155/2012/985646.
14. Okoko BJ, Wesuperuma LH, Ota MO,. et al. Influence of placental malaria infection and maternal hypergammaglobulinaemia on materno-foetal transfer of measles and tetanus antibodies in a rural West African population. J Heal Popul Nutr 2001; 19: 59-65.
15. Okoko BJ, Wesumperuma LH, Ota MO,. et al. The influence of placental malaria infection and maternal hypergammaglobulinemia on transplacental transfer of antibodies and IgG subclasses in a rural West African population. J Infect Dis 2001; 184: 627-32.
16. Okoko JB, Wesumperuma HL, Hart CA. The influence of prematurity and low birthweight on transplacental antibody transfer in a rural West African population. Trop Med Int Health 2001; 6: 529-34.
17. De Moraes-Pinto MI, Almeida AC, Kenj G,. et al. Placental transfer and maternally acquired neonatal IgG immunity in human immunodeficiency virus infection. J Infect Dis 1996; 173: 1077-84.
18. De Moraes-pinto MI, Verhoeff F, Chimsuku L,. et al. Placental antibody transfer: influence of maternal HIV infection and placental malaria. Arch Dis Child Fetal Neonatal Ed 1998; 79: F202-5.
19. Scott S, Cumberland P, Shulman CE,. et al. Neonatal measles immunity in rural Kenya: the influence of HIV and placental malaria infections on placental transfer of antibodies and levels of antibody in maternal and cord serum samples. J Infect Dis 2005; 191: 1854-60.
20. Cumberland P, Shulman CE, Maple PAC,. et al. Maternal HIV infection and placental malaria reduce transplacental antibody transfer andtetanus antibody levels in newborns in Kenya. J Infect Dis 2007; 196: 550-7.
21. Brair M-E, Brabin BJ, Milligan P, Maxwell S, Hart CA. Reduced transfer of tetanus antibodies with placental malaria. Lancet 1994; 343: 208-9.
22. Wesumperuma H, Perera A, Pharoah P, Hart C. The influence of prematurity and low birthweight on transplacental antibody transfer in Sri Lanka. Ann Trop Med Parasitol 1999; 93: 169-77.
23. Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC. Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. JAMA 2011; 305: 576-84.
24. Gupta A, Mathad JS, Yang W-T,. et al. Maternal pneumococcal capsular IgG antibodies and transplacental transfer are low in South Asian HIV-infected mother-infant pairs. Vaccine 2014; 32: 1466-72.
25. Van Den Berg JP, Westerbeek EA, Berbers GA, Van Gageldonk PG, Van Der Klis FRVan Elburg RM. Transplacental transport of IgG antibodies specific for pertussis, diphtheria, tetanus, Haemophilus influenzae type b, and Neisseria meningitidis serogroup C is lower in preterm compared with term infants. Pediatr Infect Dis J 2010; 29: 801-5.
26. Van Den Berg JP, Westerbeek EA, Smits GP, Van Der Klis FR, Berbers GA, Van Elburg RM. Lower transplacental antibody transport for measles, mumps, rubella and varicella zoster in very preterm infants. PLOS One 2014; 9: e94714.
27. Suara R, Piedra PA, Glezen WP,. et al. Prevalence of neutralizing antibody to respiratory syncytial virus in sera from mothers and newborns residing in the Gambia and in The United States. Clin Vaccine Immunol 1996; 3: 477.
28. Ochola R, Sande C, Fegan G,. et al. The level and duration of RSV-specific maternal IgG in infants in Kilifi Kenya. PLOS One 2009; 4: e8088.
29. Chu HY, Steinhoff MC, Magaret A,. et al. Respiratory syncytial virus transplacental antibody transfer and kinetics in mother-infant pairs in Bangladesh. J Infect Dis 2014; 210: 1-8.
30. World Health Organization. Papua New Guinea: Health Profile [Internet], 2012. http: //www.who.int/gho/countries/png.pdf. Accessed 8 March 2015.
31. Teo A, Hasang W, Randall LM,. et al. Decreasing malaria prevalence and its potential consequences for immunity in pregnant women. J Infect Dis 2014; 210: 1444-55.
32. Stanisic DI, Moore KA, Baiwog F,. et al. Risk factors for malaria and adverse birth outcomes in a prospective cohort of pregnant women resident in a high malaria transmission area of Papua New Guinea. Trans R Soc Trop Med Hyg 2015; 109: 313-24.
33. Unger HW, Ome-Kaius M, Wangnapi RA,. et al. Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial. BMC Med 2015; doi: 10.1186/s12916-014-0258-3.
34. Senn N, Rarau P, Stanisic DI,. et al. Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial. PLOS Med 2012; doi: 10.137/journal.pmed.1001195.
35. Umbers AJ, Boeuf P, Clapham C,. et al. Placental malaria-Associated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation. J Infect Dis 2011; 203: 561-9.
36. Jollift CR, Cost KM, Stivrins PC,. et al. Reference intervals for serum lgG, IgA, IgM, C3, and C4 as determined by rate nephelometry. Clin Chem 1982; 28: 126-8.
37. Coates H, Alling D, Chanock R. An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test. Am J Epidemiol 1966; 83: 299-313.
38. Hartter HK, Oyedele OI, Dietz K, Kreis S, Hoffman JP, Muller CP. Placental transfer and decay of maternally acquired antimeasles antibodies in Nigerian children. Pediatr Infect Dis J 2000; 19: 635-41.
39. Karl S, Li Wai Suen CS, Unger HW,. et al. Preterm or not - an evaluation of estimates of gestational age in a cohort of women from rural Papua New Guiena. PLOS One 2015; 10: e0124286.